Today: 9 June 2026
Browse Category

NSE:DIXON 10 December 2025 - 6 January 2026

Kaynes Technology share price hits fresh 52-week low as bearish signals pile up

Kaynes Technology share price hits fresh 52-week low as bearish signals pile up

Kaynes Technology shares fell over 6% Tuesday to a 52-week low of 3,747 rupees, underperforming the Sensex and peers Dixon Technologies, Amber Enterprises, and PG Electroplast. MarketsMojo downgraded its stance to “Sell” as technical signals weakened. The stock’s one-year return stands at about -47%. Trading ranged between 3,711 and 4,015.8 rupees during the session.
6 January 2026
····
Dixon Technologies share price today: Why the EMS leader fell 15% in a month, what brokerages expect on Dec 15, 2025; Lime Chemicals in focus

Dixon Technologies share price today: Why the EMS leader fell 15% in a month, what brokerages expect on Dec 15, 2025; Lime Chemicals in focus

Dixon Technologies traded near ₹13,443 on Monday after a steep month-long decline, with investors citing profit-booking, reduced promoter and FII stakes, and rising competition as key concerns. Lime Chemicals, a microcap, drew retail interest for its long-term prospects. Indian equities opened lower on weak global cues.
15 December 2025
··
Dixon Technologies share price today: Why the EMS leader fell 15% in a month, what brokerages expect on Dec 15, 2025; Lime Chemicals in focus

Dixon Technologies share price today: Why the EMS leader fell 15% in a month, what brokerages expect on Dec 15, 2025; Lime Chemicals in focus

Dixon Technologies traded near ₹13,443 on December 15 after a steep drop this month, with investors citing profit booking, reduced promoter and FII stakes, and rising competition. Lime Chemicals drew retail interest for its long-term prospects. Indian equities opened lower Monday on weak global cues, pressuring midcaps and high-beta stocks.
15 December 2025
··

Stock Market Today

  • Snap Shares Dip Amid Nasdaq Gains, Spotlight on June 16 Earnings
    June 9, 2026, 9:27 AM EDT. Snap Inc. shares declined 1.9% to $5.65, underperforming the Nasdaq Composite's 0.9% rise as investors grow cautious on its growth prospects. Despite a 12% revenue increase to $1.53 billion in Q1 and improved adjusted EBITDA, Snap faces a 46% stock drop from its 52-week high, driven by a shrinking net loss and slower ad sales growth. Competition from Meta, TikTok, and others pressures Snap's advertising revenue, while cost-cutting measures including 1,000 job cuts aim to save $500 million annually. Analyst Russ Mould highlights ongoing uncertainty about Snap's business model viability amid market challenges and delayed returns from AI and augmented reality investments ahead of the June 16 earnings focus.

Latest articles

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Go toTop